Fund Holdings — VR Adviser, LLC

Total Portfolio Value:
$1.18B
Total Bought:
$176.74M
Total Sold:
$114.07M
Net Transaction:
+$62.68M
Notable People:
Evan Wolfe Neu, Jessica Tong Baron
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Apogee Therapeutics Inc8,493,3218,493,3210$384.75M$317.31M27.00%-$67.44M
Metsera Inc03,750,662+3,750,662$0$102.09M8.69%+$102.09M
Ocular Therapeutix, Inc.(OCUL)12,762,46212,762,4620$108.99M$93.55M7.96%-$15.44M
Enliven Therapeutics Inc4,026,3314,026,3310$90.59M$79.24M6.74%-$11.35M
Kalvista Pharmaceuticals Inc6,249,7316,703,985+454,254$52.94M$77.36M6.58%+$24.43M
Viridian Therapeutics, Inc.(VRDN)3,882,7093,882,7090$74.43M$52.34M4.45%-$22.09M
Pharvaris N V
COM
3,220,1303,112,720-107,410$61.73M$48.87M4.16%-$12.86M
Spyre Therapeutics, Inc.(SYRE)2,685,4482,685,4480$62.52M$43.33M3.69%-$19.19M
Oruka Therapeutics, Inc.(ORKA)3,285,6204,148,428+862,808$63.71M$42.56M3.62%-$21.15M
Praxis Precision Medicines, Inc.(PRAX)989,985989,9850$76.19M$37.49M3.19%-$38.70M
Cogent Biosciences, Inc.(COGT)5,684,4115,684,4110$44.34M$34.05M2.90%-$10.29M
Dianthus Therapeutics, Inc.(DNTH)1,744,3731,744,3730$38.03M$31.64M2.69%-$6.38M
Dyne Therapeutics, Inc.(DYN)2,173,9132,173,9130$51.22M$22.74M1.93%-$28.48M
Cidara Therapeutics Inc765,7231,051,518+285,795$20.58M$22.65M1.93%+$2.07M
Engene Holdings Inc
COM
5,046,4145,046,4140$33.56M$22.61M1.92%-$10.95M
Erasca, Inc.(ERAS)16,216,21616,216,2160$40.70M$22.22M1.89%-$18.49M
ORIC Pharmaceuticals, Inc.(ORIC)4,394,5273,182,527-1,212,000$35.46M$17.76M1.51%-$17.71M
Upstream Bio, Inc.(UPB)2,295,3192,295,3190$37.74M$14.05M1.20%-$23.69M
Astria Therapeutics Inc2,457,3482,457,3480$21.97M$13.12M1.12%-$8.85M
Cullinan Therapeutics, Inc.(CGEM)1,379,9651,379,9650$16.81M$10.45M0.89%-$6.36M
Solid Biosciences Inc02,481,400+2,481,400$0$9.18M0.78%+$9.18M
Savara Inc.(SVRA)03,257,639+3,257,639$0$9.02M0.77%+$9.02M
ABIVAX Société AnonymeADS(ABVX)1,345,7801,345,7800$9.85M$8.41M0.72%-$1.44M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.63M$7.72M0.66%+$90.0K
Surrozen, Inc.(SRZN)0632,931+632,931$0$7.38M0.63%+$7.38M
Zura Bio LimitedCL A(ZURA)2,023,1665,023,166+3,000,000$5.06M$6.48M0.55%+$1.42M
Artiva Biotherapeutics, Inc.(ARTV)1,609,5691,609,5690$16.22M$4.83M0.41%-$11.40M
Trevi Therapeutics, Inc.(TRVI)1,266,457615,506-650,951$5.22M$3.87M0.33%-$1.35M
Applied Therapeutics Inc9,990,5915,567,709-4,422,882$8.55M$2.72M0.23%-$5.83M
4d Molecular Therapeutics In2,952,371677,600-2,274,771$16.44M$2.19M0.19%-$14.26M
CASI Pharmaceuticals, Inc.(CASIF)987,259987,2590$2.79M$2.13M0.18%-$661.5K
Tenax Therapeutics, Inc.(TENX)208,333208,3330$1.29M$1.36M0.12%+$75.0K
Mersana Therapeutics Inc10,257,7903,574,325-6,683,465$14.67M$1.23M0.10%-$13.44M
Century Therapeutics, Inc.(IPSC)3,957,1862,498,069-1,459,117$4.00M$1.19M0.10%-$2.81M
Tenaya Therapeutics, Inc.(TNYA)1,555,5561,555,5560$2.22M$886.8K0.08%-$1.34M
Glycomimetics Inc3,000,0003,000,0000$747.0K$630.0K0.05%-$117.0K
Instil Bio, Inc.(TIL)33,17733,1770$633.3K$576.0K0.05%-$57.4K
Aquestive Therapeutics Inc2,629,7860-2,629,786$9.36M$0—-$9.36M
Merus N V592,4110-592,411$24.91M$0—-$24.91M
Taysha Gene Therapies, Inc.(TSHA)3,225,1800-3,225,180$5.58M$0—-$5.58M
Terns Pharmaceuticals Inc1,077,0900-1,077,090$5.97M$0—-$5.97M
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q1 2025 | TickerTrail